Psychiatry Care Live

CME Presentations

Schizophrenia


Presentations


Speakers

  • Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Abigail L. Donovan, MD

    Director, MGH First Episode and Early Psychosis Program

    Abigail Donovan, MD, is an associate psychiatrist at Massachusetts General Hospital (MGH) and assistant professor of psychiatry at Harvard Medical School in Boston. She is also the director of the First Episode and Early Psychosis Program and associate director of the Acute Psychiatry Service at MGH. Dr Donovan’s interests include the early diagnosis and treatment of schizophrenia in adolescents, as well as systems issues and quality of care improvement in acute psychiatry. She is the co-author of a book on child emergency psychiatry, and has been published in the Journal of the American Academy of Child and Adolescent Psychiatry, and the Journal of Clinical Psychiatry, amongst others. She earned her medical degree from the Yale University School of Medicine in New Haven, Connecticut.
  • Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Oliver Freudenreich, MD, FAPM

    Co-Director, MGH Schizophrenia Clinical and Research Program

    Oliver Freudenreich, MD, FAPM, is an associate professor of psychiatry at Harvard Medical School and a psychiatrist at Massachusetts General Hospital (MGH) in Boston. He is co-director of the MGH Schizophrenia Clinical and Research Program and directs the MGH Fellowship in Public and Community Psychiatry. His academic interests include optimal psychopharmacological treatment for schizophrenia, early course schizophrenia, the role of medical morbidity in schizophrenia, the integration of medicine and psychiatry, and treatment adherence. Dr Freudenreich serves a deputy editor for the journal, Psychosomatics, is published extensively in numerous journals, and has authored a handbook on psychotic disorders. He received his medical degree from the University of Heidelberg in Germany.

CME Information

Facing Treatment Challenges in Schizophrenia


  

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Compare and contrast recently available treatment strategies for the optimal management of patients with schizophrenia
  • Employ strategies to improve treatment adherence in patients with schizophrenia

Acknowledgement

This activity is supported by educational grants from Indivior Inc. and Alkermes.

Tuition

Complimentary

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release/Expiration

Live Activity

Firday, February 2, 2018 from 1:00pm – 2:00pm EDT

Enduring Material

The enduring material will be available from February 2, 2018 to February 2, 2019.

Target Audience

This activity is intended for US-based psychiatrists and primary care clinicians, physician assistants, nurse practitioners, nurses, pharmacists, and health care providers involved in the care of patients suffering from schizophrenia.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete

Method Of Participation

There are no fees to participate in this activity. To participate in the activity, go to http://www.PsychiatryCareLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Facutly

Oliver Freudenreich, MD, FAPM
Co-Director, MGH Schizophrenia Clinical and Research Program
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School

Abigail Donovan, MD
Associate Psychiatrist
Massachusetts General Hospital
Assistant Professor of Psychiatry
Harvard Medical School

Disclosure of Conflict of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Oliver Freudenreich, MD, FAPM
Royalty: Wolters-Kluwer, UpToDate
Consulting Fees: Janssen
Contracted Research: Avanir Pharmaceuticals Inc. (PI)
Other CME Talks: Neurocrine Biosciences, Global Medical Education

Abigail Donovan, MD,
Contracted Research (Subinvestigator): Janssen
Investor (Spouse): MIRAH

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Anne Roc, PhD, None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

DISCLAIMERS

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Please send CME inquiries to: cme@bu.edu

Technical Support
For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive at 877-394-1306 or at Support@PsychiatryCareLive.com..